E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


A comparative study of efficacy of enalapril versus telmisartan in patients with diabetic nephropathy

Arpitha K S, Lakshminarayana K.

Abstract
Background: Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD) worldwide and is estimated that ~20% of type 2 diabetics develop ESRD during their lifetime. In type 2 diabetics with microalbuminuria, both enalapril and telmisartan have shown to reduce microalbuminuria, thereby delaying the progression of renal disease in diabetics.

Aim and Objective: This study aims to evaluate the efficacy of enalapril versus telmisartan among patients with DN for 6 months.

Materials and Methods: A prospective, open-labeled, randomized, comparative study was conducted involving 100 type 2 diabetics with mild hypertension and Grade I DN was divided randomly into two groups of 50 each, aged between 18 and 69 years with either sex, attending medicine outpatient department or admitted in medicine wards. One group received tab. enalapril maleate, 510 mg/day, while other group received tab. telmisartan, 4080 mg/day, and were followed up once a month for 6 months. Efficacy was assessed using urine albumin, serum urea, serum creatinine, and blood pressure (BP).

Results: Demographic and baseline urine albumin level, serum urea, serum creatinine, and BP were comparable between two groups. Early improvement in urine albumin and serum creatinine levels was seen with enalapril (at 2 months, urine albumin: P = 0; at 3 months, serum creatinine: P = 0.007). Reduction of BP was greater with telmisartan (systolic BP/diastolic BP (DBP): P < 0.001). In later phase, no significant difference was observed between two groups among the parameters such as urine albumin estimation (P = 1) and serum urea (P = 0.286).

Conclusion: Both enalapril and telmisartan were equally efficacious in DN. However, enalapril had better response than telmisartan in our study.

Key words: Diabetic Nephropathy; Hypertension; Microalbuminuria; Enalapril Maleate; Telmisartan


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Arpitha K S
Articles by Lakshminarayana K
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

S AK, K L. A comparative study of efficacy of enalapril versus telmisartan in patients with diabetic nephropathy. Natl J Physiol Pharm Pharmacol. 2020; 10(10): 894-899. doi:10.5455/njppp.2020.10.06172202003072020


Web Style

S AK, K L. A comparative study of efficacy of enalapril versus telmisartan in patients with diabetic nephropathy. http://www.njppp.com/?mno=120198 [Access: October 01, 2020]. doi:10.5455/njppp.2020.10.06172202003072020


AMA (American Medical Association) Style

S AK, K L. A comparative study of efficacy of enalapril versus telmisartan in patients with diabetic nephropathy. Natl J Physiol Pharm Pharmacol. 2020; 10(10): 894-899. doi:10.5455/njppp.2020.10.06172202003072020



Vancouver/ICMJE Style

S AK, K L. A comparative study of efficacy of enalapril versus telmisartan in patients with diabetic nephropathy. Natl J Physiol Pharm Pharmacol. (2020), [cited October 01, 2020]; 10(10): 894-899. doi:10.5455/njppp.2020.10.06172202003072020



Harvard Style

S, A. K. & K, . L. (2020) A comparative study of efficacy of enalapril versus telmisartan in patients with diabetic nephropathy. Natl J Physiol Pharm Pharmacol, 10 (10), 894-899. doi:10.5455/njppp.2020.10.06172202003072020



Turabian Style

S, Arpitha K, and Lakshminarayana K. 2020. A comparative study of efficacy of enalapril versus telmisartan in patients with diabetic nephropathy. National Journal of Physiology, Pharmacy and Pharmacology, 10 (10), 894-899. doi:10.5455/njppp.2020.10.06172202003072020



Chicago Style

S, Arpitha K, and Lakshminarayana K. "A comparative study of efficacy of enalapril versus telmisartan in patients with diabetic nephropathy." National Journal of Physiology, Pharmacy and Pharmacology 10 (2020), 894-899. doi:10.5455/njppp.2020.10.06172202003072020



MLA (The Modern Language Association) Style

S, Arpitha K, and Lakshminarayana K. "A comparative study of efficacy of enalapril versus telmisartan in patients with diabetic nephropathy." National Journal of Physiology, Pharmacy and Pharmacology 10.10 (2020), 894-899. Print. doi:10.5455/njppp.2020.10.06172202003072020



APA (American Psychological Association) Style

S, A. K. & K, . L. (2020) A comparative study of efficacy of enalapril versus telmisartan in patients with diabetic nephropathy. National Journal of Physiology, Pharmacy and Pharmacology, 10 (10), 894-899. doi:10.5455/njppp.2020.10.06172202003072020